Low expression of <scp>BARX2</scp> in human primary hepatocellular carcinoma correlates with metastasis and predicts poor prognosis

Abstract

These findings provide evidence that the low expression level of BARX2 in HCC is significantly correlated with tumor metastasis, and that BARX2 may be an independent prognostic biomarker for patients with HCC.